Zobrazeno 1 - 10
of 18
pro vyhledávání: '"David B. Liesenfeld"'
Autor:
Christoph Weigel, Marlon R. Veldwijk, Christopher C. Oakes, Petra Seibold, Alla Slynko, David B. Liesenfeld, Mariona Rabionet, Sabrina A. Hanke, Frederik Wenz, Elena Sperk, Axel Benner, Christoph Rösli, Roger Sandhoff, Yassen Assenov, Christoph Plass, Carsten Herskind, Jenny Chang-Claude, Peter Schmezer, Odilia Popanda
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-12 (2016)
Radiotherapy can induce fibrosis in cancer patients, limiting its use in clinical settings. Here, the authors identify a differentially methylated enhancer of the lipid kinase DGKA in fibroblasts from breast cancer patients developing fibrosis after
Externí odkaz:
https://doaj.org/article/8d2cbcdc585d437387a5d8eedf91802c
Autor:
Jennifer Ose, Biljana Gigic, Tengda Lin, David B. Liesenfeld, Jürgen Böhm, Johanna Nattenmüller, Dominique Scherer, Lin Zielske, Petra Schrotz-King, Nina Habermann, Heather M. Ochs-Balcom, Anita R. Peoples, Sheetal Hardikar, Christopher I. Li, David Shibata, Jane Figueiredo, Adetunji T. Toriola, Erin M. Siegel, Stephanie Schmit, Martin Schneider, Alexis Ulrich, Hans-Ulrich Kauczor, Cornelia M. Ulrich
Publikováno v:
Metabolites, Vol 9, Iss 9, p 178 (2019)
Cachexia is a multifactorial syndrome that is characterized by loss of skeletal muscle mass in cancer patients. The biological pathways involved remain poorly characterized. Here, we compare urinary metabolic profiles in newly diagnosed colorectal ca
Externí odkaz:
https://doaj.org/article/49bea54fb5644d7bbbeb3e8607750fa6
Autor:
Cornelia M. Ulrich, Johanna W. Lampe, John D. Potter, Karel D. Klika, Odilia Popanda, Christoph Weigel, Reka Toth, Nina Habermann, Akke Botma, David B. Liesenfeld
Supplementary Materials and Methods. Supplementary Figure 1: Study design of the ABC intervention study. Supplementary Figure 2: Intracellular concentrations of free salicylate in aspirin treated colorectal cancer cell lines expressed as nmol per tot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00eb4f1cf3044dfe3e96a96a8e400dfc
https://doi.org/10.1158/1055-9965.22437900
https://doi.org/10.1158/1055-9965.22437900
PDF - 217KB, Additional information regarding the search strategy used in the main paper. Supplementary Table: List of reported metabolites to be altered in human cancers. Supplementary Figure: General overview over the metabolomics workflow.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756c1e67aacc374c8357f0ff68c24fc9
https://doi.org/10.1158/1055-9965.22437652
https://doi.org/10.1158/1055-9965.22437652
Metabolomics, the systematic investigation of all metabolites present within a biologic system, is used in biomarker development for many human diseases, including cancer. In this review, we investigate the current role of mass spectrometry–based m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d931016be1db270f8f06c0e94a3568
https://doi.org/10.1158/1055-9965.c.6515992.v1
https://doi.org/10.1158/1055-9965.c.6515992.v1
Autor:
Cornelia M. Ulrich, Johanna W. Lampe, John D. Potter, Karel D. Klika, Odilia Popanda, Christoph Weigel, Reka Toth, Nina Habermann, Akke Botma, David B. Liesenfeld
Background: Aspirin use is an effective strategy for the chemoprevention of colorectal cancer, even at low doses. However, in order to implement aspirin interventions, risk–benefit balances and biologic mechanisms need to be better defined; to furt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f82dd5d92fa09860002766d09f8490f
https://doi.org/10.1158/1055-9965.c.6516111.v1
https://doi.org/10.1158/1055-9965.c.6516111.v1
Autor:
Augustin Scalbert, Tengda Lin, Petra Schrotz-King, David B. Liesenfeld, Kenneth M. Boucher, William M. Grady, Jourgen Boehm, David Shibata, Jennifer Ose, Erin M. Siegel, Alexis Ulrich, Neli Ulrich, Jincheng Shen, Jane C. Figueiredo, Ben Haaland, Adetunji T. Toriola, Christopher I. Li, Biljana Gigic, Anita R. Peoples, Martin F. Schneider, Robert W. Owen
Publikováno v:
Cancer Research. 81:892-892
Objective: High-throughput metabolomics assays can generate thousands of biomarker measurements and provide novel opportunities for prognostic modeling in colorectal cancer (CRC) research. The high dimensionality of metabolic data brings unforeseen s
Autor:
D. G. Seo, David B. Liesenfeld, Christoph Plass, Christoph Weigel, Anders Lindroth, Yoon Jung Park, Joo Hyun Park, Dieter Weichenhan, Yeongran Yoo
Publikováno v:
International Journal of Obesity. 41:652-659
Adipose tissue is one of the main organs regulating energy homeostasis via energy storage as well as endocrine function. The adipocyte cell number is largely determined by adipogenesis. While the molecular mechanism of adipogenesis has been extensive
Autor:
David B. Liesenfeld, Nina Habermann, Jennifer Ose, Martin Schneider, Hans-Ulrich Kauczor, Johanna Nattenmüller, Petra Schrotz-King, Tengda Lin, Christopher I. Li, Biljana Gigic, Alexis Ulrich, Cornelia M. Ulrich, Stephanie L. Schmit, David Shibata, Jane C. Figueiredo, Adetunji T. Toriola, Anita R. Peoples, Heather M. Ochs-Balcom, Sheetal Hardikar, Jürgen Böhm, Erin M. Siegel, Lin Zielske, Dominique Scherer
Publikováno v:
Metabolites
Volume 9
Issue 9
Metabolites, Vol 9, Iss 9, p 178 (2019)
Volume 9
Issue 9
Metabolites, Vol 9, Iss 9, p 178 (2019)
Cachexia is a multifactorial syndrome that is characterized by loss of skeletal muscle mass in cancer patients. The biological pathways involved remain poorly characterized. Here, we compare urinary metabolic profiles in newly diagnosed colorectal ca
Autor:
Jenny Chang-Claude, Christopher C. Oakes, Yassen Assenov, Marlon R. Veldwijk, David B. Liesenfeld, Christoph Rösli, Alla Slynko, Roger Sandhoff, Sabrina Hanke, Christoph Weigel, Petra Seibold, Mariona Rabionet, Elena Sperk, Axel Benner, Peter Schmezer, Odilia Popanda, Carsten Herskind, Frederik Wenz, Christoph Plass
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-12 (2016)
Nature Communications
Nature Communications
Radiotherapy is a fundamental part of cancer treatment but its use is limited by the onset of late adverse effects in the normal tissue, especially radiation-induced fibrosis. Since the molecular causes for fibrosis are largely unknown, we analyse if